Table 1.
Baseline Patient and Study Eye Characteristics (mITT Population)
| Parameter | DEX (N = 145) | Laser (N = 127) |
|---|---|---|
| Age, mean (SD), years | 59.1 (8.1) | 59.5 (7.7) |
| Male gender, n (%) | 81 (55.9) | 58 (45.7) |
| Race: Asian, n (%) | 145 (100) | 127 (100) |
| Ethnicity, n (%) | ||
| Chinese | 129 (89.0) | 113 (89.0) |
| Other | 16 (11.0) | 14 (11.0) |
| Lens status, n (%) | ||
| Phakic | 109 (75.2) | 100 (78.7) |
| Pseudophakic | 36 (24.8) | 27 (21.3) |
| Duration of DME, median (25%, 75% percentile), months | 7.1 (0.7, 20.0) |
6.9 (0.6, 21.8) |
| BCVA, mean (SD), letters | 55.7 (11.4) | 55.1 (10.3) |
| 34–49 letters, n (%) | 43 (29.7) | 33 (26.0) |
| 50–70 letters, n (%) | 102 (70.3) | 94 (74.0) |
| CRT, mean (SD), µm | 491.2 (160.8) | 482.1 (154.4) |
| Total macular leakage area, mean (SD), mm2 | 29.6 (10.4) | 30.1 (9.6) |
| IOP, mean (SD), mmHg | 15.2 (3.3) | 15.3 (2.9) |
Abbreviations: BCVA, best-corrected visual acuity; CRT, central retinal thickness; DEX, dexamethasone intravitreal implant 0.7 mg; DME, diabetic macular edema; IOP, intraocular pressure; mITT, modified intent-to-treat; SD, standard deviation.